Marder, SR, Essock, SM, Miller, AL, Buchanan, RW, Casey, DE, Davis, JM, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry
2004; 161: 1334–49.
Brown, S, Barraclough, B, Inskip, H.
Causes of the excess mortality of schizophrenia. Br J Psychiatry
2000; 177: 212–7.
Hamilton, R, Harrison, M, Naji, S, Robertson, C.
Service innovation: the first year of lifestyle clinics for psychiatric out-patients. Psychiatr Bull
2009; 33: 445–448.
Brugha, TS, Wing, JK, Smith, BL. Physical health of the long-term mentally ill in the community. Is there unmet need?
Br J Psychiatry
1989; 155: 777–81.
Koran, LM, Sox, HC, Marton, KI, Moltzen, S, Sox, CH, Kraemer, HC, et al. Medical evaluation of psychiatric patients. 1. Results in a state of mental health system. Arch Gen Psychiatry
1989; 46: 733–40.
National Institute for Clinical Excellence. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. NICE, 2002.
Department of Health. National Service Framework for Mental Health. Department of Health, 1999.
Department of Health. Public Health White Paper. Choosing Health: Making Healthier Choices Easier. Department of Health, 2004.
Department of Health. Standards for Better Health. Department of Health, 2004.
Disability Rights Commission. Equal Treatment: Closing the Gap. Disability Rights Commission, 2006.
Nasrallah, HA, Meyer, JM, Goff, DC, McEvoy, JP, Davis, SM, Stroup, TS, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res
2006; 86: 15–22.
Kreyenbuhl, J, Medoff, DR, Seliger, SL, Dixon, LB. Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetes. Schizophr Res
2008; 101: 256–65.
Lambert, TJ, Velakoulis, D, Pantelis, C.
Medical comorbidity in schizophrenia. Med J Aust
2003; 178 (suppl): S67–70.
Kotter, JP. Leading change: why transformation efforts fail?
Harv Bus Rev
1995; : 1–10.
Barnes, TR, Paton, C, Hancock, E, Cavanagh, MR, Taylor, D, Lelliott, P.
UK Prescribing Observatory for Mental Health. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme. Acta Psychiatr Scand
2008; 118: 26–33.
Department of Health. Chief Nursing Officer's Review of Mental Health Nursing. Department of Health, 2006.
Goff, DC, Sullivan, LM, McEvoy, JP, Meyer, JM, Nasrallah, HA, Daumit, GL, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res
2005; 80: 45–53.
Batki, SL, Meszaros, ZS, Strutynski, K, Dimmock, JA, Leontieva, L, Ploutz-Snyder, R, et al. Medical comorbidity in patients with schizophrenia and alcohol dependence. Schizophr Res
2009; 107: 139–46.
Isaac, M, Isaac, M, Holloway, F.
Is cannabis an anti-antipsychotic? the experience in psychiatric intensive care. Hum Psychopharmacol
2005; 20: 207–10.